Citations

Clear

299 citation(s) found for "Solomon, B".

Free Fatty Acid-Induced Hepatic Insulin Resistance is Attenuated Following Lifestyle Intervention in Obese Individuals with Impaired Glucose Tolerance
Haus, Jacob M. , Solomon, Thomas P. J. , Marchetti, Christine M., Edmison, John M., González, Frank , Kirwan, John P.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | November 11, 2009 | Volume: 95 | Issue: 1 | Pages: 323-327

10.1210/jc.2009-1101 | PMID 19906790 Get It

The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
Prestwich, Robin, Errington‐Mais, Fiona , Díaz, Rosa María, Pandha, Hardev , Harrington, Kevin J. , Melcher, Alan , Vile, Richard G. , Errington-Mais, Fiona , Melcher, Alan A , Harrington, Kevin

Mayo Clinic

Human Gene Therapy | July 24, 2009 | Volume: 20 | Issue: 10 | Pages: 1119-1132

10.1089/hum.2009.135 | PMID 19630549 Get It

Acute Painless Shoulder Weakness during High-Intensity Athletic Training
Vachon, Tyler , Rosenthal, Michael D. , Dewing, Christopher B., Shin, Alexander Y. , Provencher, Matthew T. , Solomon, Daniel Jordan , Shin, Alexander Y

Mayo Clinic

The American Journal of Sports Medicine | January 5, 2009 | Volume: 37 | Issue: 1 | Pages: 175-180

10.1177/0363546508328101 | PMID 19124836 Get It

Background High-intensity repetitive athletic activities may predispose the brachial plexus to repetitive stretch, compression, and subsequent injury, although painless shoulder weakness is a rare event. Purpose The physical examination and electrodiagnostic findings in a series of United States Navy special warfare trainees who presented with acute painless shoulder weakness are presented, along with subsequent treatment and return-to-duty timeline. Study Design Case series; Level of evidence, 4. Methods From August 2005 to August 2006, a total of 11 of 212 (5%) Navy Basic Underwater Demolition School trainees were identified with acute onset (<3 weeks) painless shoulder weakness without any prior shoulder injury. In all shoulders, symptoms began during a telephone pole lift-carry drill. All trainees underwent serial examinations, electrodiagnostic testing, and a comprehensive rehabilitation program. Results Physical examination revealed universal weakness in flexion and abduction and electrodiagnostic studies confirmed injury to the C5-6 area of the brachial plexus (axillary, suprascapular, and musculocutaneous). All 11 patients were removed from training and started on a physical therapy program until functional recovery at a mean of 21 weeks after onset of symptoms (range, 12-24). All 11 resumed military activities; however, only 6 completed the Navy Basic Underwater Demolition School program. Conclusion In physically intense training or athletic environments, injuries to the upper brachial plexus may present with various forms of upper extremity dysfunction, including painless shoulder weakness. This information provides insight into a potentially debilitating shoulder problem and offers guidance on future training principles.
IGF-I, IGFBP-3, and IGF-I/IGFBP-3 Ratio: No Association with Incident Colorectal Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
Max, Joshua, Ogunseitan, Adeboye, Vierkant, Robert A. , Pollak, Michael J., Sellers, Thomas A. , Virtamo, Jarmo, Cerhan, James R. , Pollak, Michaël , Limburg, Paul J. , Stolzenberg‐Solomon, Rachael Z. , Pollak, Michael J., Albanes, Demetrius , Cerhan, James R , Vierkant, Robert A , Pollak, Michael N

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | July 15, 2008 | Volume: 17 | Issue: 7 | Pages: 1832-1834

10.1158/1055-9965.epi-08-0345 | PMID 18628438 Get It

Influence of Albuminuria on Cardiovascular Risk in Patients With Stable Coronary Artery Disease
Solomon, Scott D. , Lin, Julie , Solomon, Caren G. , Jablonski, Kathleen A., Rice, Madeline Murguia , Steffes, Michael W., Domanski, Michaël, Arnold, J. Malcolm O., Rouleau, Jean L. , Solomon, Scott David , Hsia, Judith A. , Gersh, Bernard J. , Braunwald, Eugene , Pfeffer, Marc Alan

Mayo Clinic

Circulation | November 20, 2007 | Volume: 116 | Issue: 23 | Pages: 2687-2693

10.1161/circulationaha.107.723270 | PMID 18025537 Get It

Background— Patients with chronic kidney disease are at increased risk for cardiovascular morbidity and mortality. We assessed the association between albuminuria and the risks for death and cardiovascular events among patients with stable coronary disease. Methods and Results— We studied patients enrolled in the Prevention of Events with an ACE inhibitor (PEACE) trial, in which patients with chronic stable coronary disease and preserved systolic function were randomized to trandolapril or placebo and followed up for a median of 4.8 years. The urinary albumin to creatinine ratio (ACR) assessed in a core laboratory in 2977 patients at baseline and in 1339 patients at follow-up (mean 34 months) was related to estimated glomerular filtration rate and outcomes. The majority of patients (73%) had a baseline ACR within the normal range (<17 μg/mg for men and <25 μg/mg for women). Independent of the estimated glomerular filtration rate and other baseline covariates, a higher ACR, even within the normal range, was associated with increased risks for all-cause mortality ( P <0.001) and cardiovascular death ( P =0.01). The effect of trandolapril therapy on outcomes was not modified significantly by the level of albuminuria. Nevertheless, trandolapril therapy was associated with a significantly lower mean follow-up ACR (12.5 versus 14.6 μg/mg, P =0.0002), after adjustment for baseline ACR, time between collections, and other covariates. An increase in ACR over time was associated with increased risk of cardiovascular death (hazard ratio per log ACR 1.74, 95% CI 1.08 to 2.82). Conclusions— Albuminuria, even in low levels within the normal range, is an independent predictor of cardiovascular and all-cause mortality.
Letter Regarding Article by Gazzaruso et al, “Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Apparently Uncomplicated Type 2 Diabetic Patients”
Jackson, Graham, Solomon, Hemant, Wierzbicki, Anthony S.

Mayo Clinic

Circulation | January 18, 2005 | Volume: 111 | Issue: 2 | Pages: No page available

10.1161/01.cir.0000152482.71628.51 | PMID 15657383 Get It

Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins.
Minoo, Parviz , Sullivan, W. Patrick, Solomon, Luc, Martin, Terence E., Toft, D O, Scott, R E

Mayo Clinic

The Journal of cell biology | May 15, 2004 | Volume: 109 | Issue: 5 | Pages: 1937-1946

10.1083/jcb.109.5.1937 | PMID 2808514 Get It

The decrease in abundance of a subset of highly conserved basic nuclear proteins is established to correlate with the loss of proliferative potential in association with the process of terminal differentiation in murine mesenchymal stem cells and human keratinocytes. These proteins, designated P2Ps for proliferation potential proteins, have apparent molecular masses of 30-40 kD, are associated with the 30-40S substructures of nuclear hnRNP complexes, and are recognized by antibodies made against core proteins of hnRNP particles. They also share an epitope in common with heat shock protein-90 (hsp90) and are recognized by two mAbs against hsp90. Two-dimensional electrophoretic Western blots furthermore show that P2Ps make up a subset of hnRNP proteins. Cells that possess these proteins express the potential to proliferate whether or not they are traversing the cell cycle. These include rapidly growing cells, reversibly growth-arrested cells, and nonterminally differentiated cells. In contrast, cells that have irreversibly lost their proliferative potential, such as terminally differentiated cells, show a marked reduction in the abundance of P2Ps as determined by immunodetection on Western blots. A correlation, therefore, exists between the presence of this subset of nuclear proteins and the proliferative potential in two cell types. These results raise the possibility that as a subset of hnRNP proteins, P2Ps may mediate posttranscriptional control of the processing of specific RNAs required for cell proliferation.
Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: Evidence from genomic deletion of biosynthetic enzymes
Xue, L., Farrugia, Gianrico , Miller, Steven M. , Ferris, C D, Snyder, Solomon H. , Szurszewski, Joseph H., Xue, L.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 97 | Issue: 4 | Pages: 1851-1855

10.1073/pnas.97.4.1851 | PMID 10677545 Get It

Nitric oxide (NO) and carbon monoxide (CO) seem to be neurotransmitters in the brain. The colocalization of their respective biosynthetic enzymes, neuronal NO synthase (nNOS) and heme oxygenase-2 (HO2), in enteric neurons and altered intestinal function in mice with genomic deletion of the enzymes ( nNOS Δ/Δ and HO2 Δ/Δ ) suggest neurotransmitter roles for NO and CO in the enteric nervous system. We now establish that NO and CO are both neurotransmitters that interact as cotransmitters. Small intestinal smooth muscle cells from nNOS Δ/Δ and HO2 Δ/Δ mice are depolarized, with apparent additive effects in the double knockouts ( HO2 Δ/Δ / nNOS Δ/Δ ). Muscle relaxation and inhibitory neurotransmission are reduced in the mutant mice. In HO2 Δ/Δ preparations, responses to electrical field stimulation are nearly abolished despite persistent nNOS expression, whereas exogenous CO restores normal responses, indicating that the NO system does not function in the absence of CO generation.